These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 29293366)
21. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes. Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923 [TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy. Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography. Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970 [TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. Ong LT; Dunphy M; Foster A; Woo KM; Zhang Z; Perez CA; Pietanza CM; Rosenzweig KE; Gelblum DY; Rimner A; Wu AJ Clin Lung Cancer; 2016 May; 17(3):184-8. PubMed ID: 26320828 [TBL] [Abstract][Full Text] [Related]
25. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma. Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634 [TBL] [Abstract][Full Text] [Related]
26. Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis. Carpenter DJ; Jacobs CD; Wong TZ; Craciunescu O; Chino JP Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):356-366. PubMed ID: 31254659 [TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes of cervical cancer patients with complete metabolic response after definitive chemoradiotherapy. Onal C; Guler OC; Reyhan M; Yapar AF J Gynecol Oncol; 2021 Sep; 32(5):e74. PubMed ID: 34378362 [TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of Metabolic Parameters of Metastatic Lymph Nodes on Jin F; Qu B; Fu Z; Zhang Y; Han A; Kong L; Yu J Clin Lung Cancer; 2018 Jan; 19(1):e101-e108. PubMed ID: 28690012 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer. Hong JH; Jung US; Min KJ; Lee JK; Kim S; Eo JS Nucl Med Commun; 2016 Aug; 37(8):843-8. PubMed ID: 27058362 [TBL] [Abstract][Full Text] [Related]
30. Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer. Leseur J; Roman-Jimenez G; Devillers A; Ospina-Arango JD; Williaume D; Castelli J; Terve P; Lavoue V; Garin E; Lejeune F; Acosta O; De Crevoisier R Radiother Oncol; 2016 Sep; 120(3):512-518. PubMed ID: 27569847 [TBL] [Abstract][Full Text] [Related]
31. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma. Sun Y; Lu P; Yu L Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968 [TBL] [Abstract][Full Text] [Related]
32. Texture analysis of Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542 [TBL] [Abstract][Full Text] [Related]
33. The Role of the Metabolic Parameters of Wang D; Liu X; Wang W; Huo L; Pan Q; Ren X; Zhang F; Hu K Front Oncol; 2021; 11():698744. PubMed ID: 34490094 [TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma. Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy. Onal C; Guler OC; Reyhan M; Yapar AF Gynecol Oncol; 2015 Apr; 137(1):40-6. PubMed ID: 25641567 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of metabolic tumour volume and total lesion glycolysis in Jiménez-Ballvé A; García García-Esquinas M; Salsidua-Arroyo O; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Fuentes Ferrer ME; Rodríguez Rey C; Román-Santamaría JM; Moreno F; Carreras-Delgado JL Rev Esp Med Nucl Imagen Mol; 2016; 35(6):365-372. PubMed ID: 26948652 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
38. Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer. Martinez A; Chantalat E; Angeles MA; Ferron G; Ducassou A; Daix M; Attal J; Bétrian S; Lusque A; Gabiache E BMC Cancer; 2022 Jul; 22(1):810. PubMed ID: 35870900 [TBL] [Abstract][Full Text] [Related]
39. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters. Chang S; Kim SJ Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]